REPROS THERAPEUTICS INC's ticker is RPRX and the CUSIP is 76028H209. A total of 62 filers reported holding REPROS THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.10 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $2,000 | +100.0% | 2,700 | 0.0% | 0.00% | – |
Q3 2017 | $1,000 | 0.0% | 2,700 | 0.0% | 0.00% | – |
Q2 2017 | $1,000 | -66.7% | 2,700 | 0.0% | 0.00% | – |
Q1 2017 | $3,000 | -25.0% | 2,700 | 0.0% | 0.00% | -100.0% |
Q4 2016 | $4,000 | -33.3% | 2,700 | 0.0% | 0.00% | 0.0% |
Q3 2016 | $6,000 | +50.0% | 2,700 | 0.0% | 0.00% | 0.0% |
Q2 2016 | $4,000 | +33.3% | 2,700 | 0.0% | 0.00% | 0.0% |
Q1 2016 | $3,000 | 0.0% | 2,700 | 0.0% | 0.00% | 0.0% |
Q4 2015 | $3,000 | -85.0% | 2,700 | 0.0% | 0.00% | -75.0% |
Q3 2015 | $20,000 | – | 2,700 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
SPHERA FUNDS MANAGEMENT LTD. | 978,800 | $1,292,000 | 0.33% |
Allegis Investment Advisors, LLC | 344,487 | $455,000 | 0.14% |
GENERAL AMERICAN INVESTORS CO INC | 589,768 | $778,000 | 0.08% |
Acrospire Investment Management LLC | 23,177 | $31,000 | 0.01% |
JACOBS LEVY EQUITY MANAGEMENT, INC | 268,130 | $354,000 | 0.01% |
Alambic Investment Management, L.P. | 16,091 | $21,000 | 0.00% |
OXFORD ASSET MANAGEMENT LLP | 51,359 | $68,000 | 0.00% |
Renaissance Technologies | 716,413 | $946,000 | 0.00% |
BENJAMIN F. EDWARDS & COMPANY, INC. | 2,700 | $4,000 | 0.00% |
Virtu KCG Holdings LLC | 45,144 | $60,000 | 0.00% |